Stephanie H. Kim
University of California, San Diego
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephanie H. Kim.
Nature Immunology | 2017
Boyko Kakaradov; Janilyn Arsenio; Christella E. Widjaja; Zhaoren He; Stefan Aigner; Patrick J. Metz; Bingfei Yu; Ellen J. Wehrens; Justine Lopez; Stephanie H. Kim; Elina I. Zuniga; Ananda W. Goldrath; John T. Chang; Gene W. Yeo
During microbial infection, responding CD8+ T lymphocytes differentiate into heterogeneous subsets that together provide immediate and durable protection. To elucidate the dynamic transcriptional changes that underlie this process, we applied a single-cell RNA-sequencing approach and analyzed individual CD8+ T lymphocytes sequentially throughout the course of a viral infection in vivo. Our analyses revealed a striking transcriptional divergence among cells that had undergone their first division and identified previously unknown molecular determinants that controlled the fate specification of CD8+ T lymphocytes. Our findings suggest a model for the differentiation of terminal effector cells initiated by an early burst of transcriptional activity and subsequently refined by epigenetic silencing of transcripts associated with memory lymphocytes, which highlights the power and necessity of single-cell approaches.
Journal of Immunology | 2015
Patrick J. Metz; Janilyn Arsenio; Boyko Kakaradov; Stephanie H. Kim; Kelly A. Remedios; Katherine Oakley; Kazunori Akimoto; Shigeo Ohno; Gene W. Yeo; John T. Chang
During an immune response against a microbial pathogen, activated naive T lymphocytes give rise to effector cells that provide acute host defense and memory cells that provide long-lived immunity. It has been shown that T lymphocytes can undergo asymmetric division, enabling the daughter cells to inherit unequal amounts of fate-determining proteins and thereby acquire distinct fates from their inception. In this study, we show that the absence of the atypical protein kinase C (PKC) isoforms, PKCζ and PKCλ/ι, disrupts asymmetric CD8+ T lymphocyte division. These alterations were associated with aberrant acquisition of a pre-effector transcriptional program, detected by single-cell gene expression analyses, in lymphocytes that had undergone their first division in vivo and enhanced differentiation toward effector fates at the expense of memory fates. Together, these results demonstrate a role for atypical PKC in regulating asymmetric division and the specification of divergent CD8+ T lymphocyte fates early during an immune response.
Scientific Reports | 2017
Christopher D. Kassotis; Lauren Masse; Stephanie H. Kim; Jennifer J. Schlezinger; Thomas F. Webster; Heather M. Stapleton
The potential for chemical exposures to exacerbate the development and/or prevalence of metabolic disorders, such as obesity, is currently of great societal concern. Various in vitro assays are available to assess adipocyte differentiation, though little work has been done to standardize protocols and compare models effectively. This study compares several adipogenic cell culture systems under a variety of conditions to assess variability in responses. Two sources of 3T3-L1 preadipocytes as well as OP9 preadipocytes were assessed for cell proliferation and triglyceride accumulation following different induction periods and using various tissue culture plates. Both cell line and cell source had a significant impact on potencies and efficacies of adipogenic chemicals. Gene expression analyses suggested that differential expression of nuclear receptors involved in adipogenesis underlie the differences between OP9 and 3T3-L1 cells; however, there were also differences based on 3T3-L1 cell source. Induction period modulated potency and efficacy of response depending on cell line and test chemical, and large variations were observed in triglyceride accumulation and cell proliferation between brands of tissue culture plates. Our results suggest that the selection of a cell system and differentiation protocol significantly impacts the detection of adipogenic chemicals, and therefore, influences reproducibility of these studies.
Oncotarget | 2016
Asoka Banno; Daniel A. Garcia; Eric D. van Baarsel; Patrick J. Metz; Kathleen M. Fisch; Christella E. Widjaja; Stephanie H. Kim; Justine Lopez; Aaron N. Chang; Paul P. Geurink; Bogdan I. Florea; Hermen S. Overkleeft; Huib Ovaa; Jack D. Bui; Jing Yang; John T. Chang
The epithelial-mesenchymal transition (EMT) endows carcinoma cells with phenotypic plasticity that can facilitate the formation of cancer stem cells (CSCs) and contribute to the metastatic cascade. While there is substantial support for the role of EMT in driving cancer cell dissemination, less is known about the intracellular molecular mechanisms that govern formation of CSCs via EMT. Here we show that β2 and β5 proteasome subunit activity is downregulated during EMT in immortalized human mammary epithelial cells. Moreover, selective proteasome inhibition enabled mammary epithelial cells to acquire certain morphologic and functional characteristics reminiscent of cancer stem cells, including CD44 expression, self-renewal, and tumor formation. Transcriptomic analyses suggested that proteasome-inhibited cells share gene expression signatures with cells that have undergone EMT, in part, through modulation of the TGF-β signaling pathway. These findings suggest that selective downregulation of proteasome activity in mammary epithelial cells can initiate the EMT program and acquisition of a cancer stem cell-like phenotype. As proteasome inhibitors become increasingly used in cancer treatment, our findings highlight a potential risk of these therapeutic strategies and suggest a possible mechanism by which carcinoma cells may escape from proteasome inhibitor-based therapy.
Journal of Immunology | 2015
Brigid S. Boland; Christella E. Widjaja; Asoka Banno; Bing Zhang; Stephanie H. Kim; Samantha Stoven; Michael R. Peterson; Marilyn C. Jones; H. Irene Su; Sheila E. Crowe; Jack D. Bui; Samuel B. Ho; Yoshinaga Okugawa; Ajay Goel; Eric V. Marietta; Mahdieh Khosroheidari; Kristen Jepsen; José Aramburu; Cristina López-Rodríguez; William J. Sandborn; Joseph A. Murray; Olivier Harismendy; John T. Chang
The link between autoimmune diseases and primary immunodeficiency syndromes has been increasingly appreciated. Immunologic evaluation of a young man with autoimmune enterocolopathy and unexplained infections revealed evidence of immunodeficiency, including IgG subclass deficiency, impaired Ag-induced lymphocyte proliferation, reduced cytokine production by CD8+ T lymphocytes, and decreased numbers of NK cells. Genetic evaluation identified haploinsufficiency of NFAT5, a transcription factor regulating immune cell function and cellular adaptation to hyperosmotic stress, as a possible cause of this syndrome. Inhibition or deletion of NFAT5 in normal human and murine cells recapitulated several of the immune deficits identified in the patient. These results provide evidence of a primary immunodeficiency disorder associated with organ-specific autoimmunity linked to NFAT5 deficiency.
Journal of Immunology | 2017
Jane Klann; Kelly A. Remedios; Stephanie H. Kim; Patrick J. Metz; Justine Lopez; Lauren Mack; Ye Zheng; Mark H. Ginsberg; Brian G. Petrich; John T. Chang
Talin, a cytoskeletal protein essential in mediating integrin activation, has been previously shown to be involved in the regulation of T cell proliferation and function. In this study, we describe a role for talin in maintaining the homeostasis and survival of the regulatory T (Treg) cell pool. T cell–specific deletion of talin in Tln1fl/flCd4Cre mice resulted in spontaneous lymphocyte activation, primarily due to numerical and functional deficiencies of Treg cells in the periphery. Peripheral talin-deficient Treg cells were unable to maintain high expression of IL-2Rα, resulting in impaired IL-2 signaling and ultimately leading to increased apoptosis through downregulation of prosurvival proteins Bcl-2 and Mcl-1. The requirement for talin in maintaining high IL-2Rα expression by Treg cells was due, in part, to integrin LFA-1–mediated interactions between Treg cells and dendritic cells. Collectively, our data suggest a critical role for talin in Treg cell–mediated maintenance of immune homeostasis.
Scientific Reports | 2016
Patrick J. Metz; Justine Lopez; Stephanie H. Kim; Kazunori Akimoto; Shigeo Ohno; John T. Chang
Naïve CD8+ T lymphocytes responding to microbial pathogens give rise to effector T cells that provide acute defense and memory T cells that provide long-lived immunity. Upon activation, CD8+ T lymphocytes can undergo asymmetric division, unequally distributing factors to the nascent daughter cells that influence their eventual fate towards the effector or memory lineages. Individual loss of either atypical protein kinase C (aPKC) isoform, PKCζ or PKCλ/ι, partially impairs asymmetric divisions and increases CD8+ T lymphocyte differentiation toward a long-lived effector fate at the expense of memory T cell formation. Here, we show that deletion of both aPKC isoforms resulted in a deficit in asymmetric divisions, increasing the proportion of daughter cells that inherit high amounts of effector fate-associated molecules, IL-2Rα, T-bet, IFNγR, and interferon regulatory factor 4 (IRF4). However, unlike CD8+ T cells deficient in only one aPKC isoform, complete loss of aPKC unexpectedly increased CD8+ T cell differentiation toward a short-lived, terminal effector fate, as evidenced by increased rates of apoptosis and decreased expression of Eomes and Bcl2 early during the immune response. Together, these results provide evidence for an important role for asymmetric division in CD8+ T lymphocyte fate specification by regulating the balance between effector and memory precursors at the initiation of the adaptive immune response.
Journal of Immunology | 2018
Jane Klann; Stephanie H. Kim; Kelly A. Remedios; Zhaoren He; Patrick J. Metz; Justine Lopez; Tiffani Tysl; Jocelyn G. Olvera; Jailal N. G. Ablack; Joseph M. Cantor; Brigid S. Boland; Gene Yeo; Ye Zheng; Li-Fan Lu; Jack D. Bui; Mark H. Ginsberg; Brian G. Petrich; John T. Chang
Maintenance of the regulatory T (Treg) cell pool is essential for peripheral tolerance and prevention of autoimmunity. Integrins, heterodimeric transmembrane proteins consisting of α and β subunits that mediate cell-to-cell and cell-to-extracellular matrix interactions, play an important role in facilitating Treg cell contact–mediated suppression. In this article, we show that integrin activation plays an essential, previously unappreciated role in maintaining murine Treg cell function. Treg cell–specific loss of talin, a β integrin–binding protein, or expression of talin(L325R), a mutant that selectively abrogates integrin activation, resulted in lethal systemic autoimmunity. This dysfunction could be attributed, in part, to a global dysregulation of the Treg cell transcriptome. Activation of integrin α4β1 led to increased suppressive capacity of the Treg cell pool, suggesting that modulating integrin activation on Treg cells may be a useful therapeutic strategy for autoimmune and inflammatory disorders. Taken together, these results reveal a critical role for integrin-mediated signals in controlling peripheral tolerance by virtue of maintaining Treg cell function.
Gastroenterology | 2014
Brigid S. Boland; Christella E. Widjaja; Asoka Banno; Stephanie H. Kim; Michael R. Peterson; Marilyn C. Jones; H.I. Su; Sheila E. Crowe; Jack D. Bui; José Aramburu; Cristina López-Rodríguez; William J. Sandborn; John T. Chang
Recent genome-wide association studies have uncovered genetic links for a number of complex diseases, but these powerful tools have not yet been widely applied to the clinical management of disease. Here we describe our experience using a genetic approach to uncover newmolecular insights in a young patient presenting with unexplained infections and chronic intestinal inflammation whomwe eventually diagnosed with anti-goblet cell antibody positive autoimmune enterocolopathy. Using a single-nucleotide polymorphism (SNP) array, we identified a deletion of the gene Nuclear Factor of Activated T cells-5 (NFAT5) in one chromosome in the patient and verified this deficiency at the mRNA and protein levels. In mice, NFAT5 has previously been shown to regulate cellular responses to osmotic stress and to play a critical role in influencing differentiation of pro-inflammatory T helper 17 (Th17) lymphocytes. We demonstrate for the first time that human NFAT5 deficiency appears to result in functional defects in both innate and adaptive immunity, with a markedly reduced number of natural killer (NK) cells, and impaired proliferation and cytokine production by T lymphocytes. We confirm the molecular link between immune cell function and NFAT5 deficiency using human cells as well as cells from mice deficient in NFAT5. Together our approach and observations demonstrate the potential power of genetic analyses to facilitate clinical diagnosis and to provide novel mechanistic insights into disease.
Nature Immunology | 2014
Janilyn Arsenio; Boyko Kakaradov; Patrick J. Metz; Stephanie H. Kim; Gene W. Yeo; John T. Chang